Increased Rate of Prophylaxis Against Venous Thromboembolism Due to eAlerts

University of Zurich10,000 enrolled

Overview

Now, after a cluster randomized controlled trial, eAlerts providing evidence-based guidelines on venous thromboembolism prophylaxis will be rolled out and evaluated hospital-widely.

An eAlert is displayed in the electronic patient chart if no prophylaxis has been ordered within 6 h after admission or transfer. The eAlerts provide evidence-based guidelines on venous thromboembolism prophylaxis. Now, after a cluster randomized controlled trial, the eAlerts will be rolled out and evaluated hospital-widely.

Study Type

INTERVENTIONAL

Allocation

Purpose

HEALTH_SERVICES_RESEARCH

Masking

SINGLE

Enrollment

10,000

Conditions

Venous Thromboembolism

Interventions

electronic alertsBEHAVIORAL

An eAlert is displayed in the electronic patient chart if no prophylaxis has been ordered within 6 h after admission or transfer.

Eligibility

Sex: ALLMin age: 16 Years

Medical Language ↔ Plain English

Inclusion criteria: * all in-patients hospitalized in a ward with computerized physician order entry (CPOE), * staying at least 24 h in a ward Exclusion criteria: * outpatients, * ward without CPOE, * patients transferred from an intervention to a control ward and vice versa

Locations (1)

University Hospital Zurich, Center for Clinical Research

Zurich, Switzerland

Outcomes

Primary Outcomes

Rate of prophylaxis against venous thromboembolism

patients with prophylaxis/total patients

Time frame: 3 months

Secondary Outcomes

ordering time after admission or transfer of a patient

time when physicians order a venous thromboembolism prophylaxis

Time frame: 3 months

acceptance of the eAlerts

survey of compliant and incompliant physicians

Time frame: 3 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.